Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacyThierry Landre, Gaëtan Des GuetzSoins. Gerontologie|September 18, 2017
[Checkpoint inhibitors, the perspectives for elderly patients]Thierry Landre, Fatima Karaoud, Cherifa TalebJournal of Chemotherapy (Florence, Italy)|February 2, 2024
Clinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC)Thierry Landre, Christos Chouaïd, Nassyma Sadaoui, et al.Drugs & Aging|July 19, 2020
Immune Checkpoint Inhibitors for Patients Aged ≥ 75 Years with Advanced Cancer in First- and Second-Line Settings: A Meta-AnalysisThierry Landre, Gaetan Des Guetz, Kader Chouahnia, et al.Cancers|December 10, 2021
Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-AnalysisGaëtan Des Guetz, Thierry Landre, Marc A Bollet, et al.Cancers|April 3, 2021
Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-AnalysisSébastien Gendarme, Helene Goussault, Jean-Baptiste Assié, et al.Journal of Cancer Research and Clinical Oncology|November 6, 2019
First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or < 1% PD-L1-expressing metastatic non-small-cell lung cancersThierry Landre, Gaetan Des Guetz, Kader Chouahnia, et al.Soins. Gerontologie|February 16, 2013
[Assessment of nursing needs and risk management in geriatric oncology]Cherifa Taleb, Thierry Landre, Eric Bertrand, et al.Clinical Genitourinary Cancer|June 23, 2019
Is There a Benefit of Addition Docetaxel, Abiraterone, Celecoxib, or Zoledronic Acid in Initial Treatments for Patients Older Than 70 Years With Hormone-sensitive Advanced Prostate Cancer? A Meta-analysisThierry Landre, Gaetan Des Guetz, Kader Chouahnia, et al.Therapeutic Advances in Medical Oncology|December 21, 2020
First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysisThierry Landre, Kader Chouahnia, Gaëtan Des Guetz, et al.Pageof 2